Dr Claude Mambo Muvunyi, MD, PhD – Rwanda

Professor of Clinical Microbiology, Director General, Rwanda Biomedical Center
Department of Medical Biology,
Centre Hospitalier  Universitaire-Butare,
National University of Rwanda
Box 227 Butare, Rwanda.
Microbiology & Infectious Diseases, College of Medicine and Health Sciences, University of Rwanda, Kigali
Tel (00250) 08493814.
E-mail: clmambo@yahoo.fr,  or cmuvunyi@nur.ac.rw 

Prof. Claude Mambo MUVUNYI is the Director General of Rwanda Biomedical Centre. He has more than 10 years of technical, managerial, and strategic experience and expertise in the field of clinical and public laboratory medicine with special focus on clinical microbiology, laboratory systems and service strengthening, and global health security.

Prof. Claude Mambo MUVUNYI is currently a full professor of clinical Microbiology and Laboratory Medicine. He holds a degree in general medicine from the university of Rwanda, a specialization and a PhD in Clinical Microbiology from the University of Ghent, Belgium. He also holds a master’s in medical Virology from the University of Manchester.

Prior to joining the RBC, Prof. Claude Mambo MUVUNYI was a Senior Regional Laboratory Advisor at ICAP at Columbia University, providing technical and strategic leadership support to the Laboratory program/project in building quality assured diagnostic capacities at all levels in the network (public and private health laboratories). He has also been a senior consultant for World Health Organization (WHO) supporting WHO’s programs for Antimicrobial Resistance (AMR) surveillance and diagnostic capacity building for infectious disease in African countries. He has been the Head of National reference Laboratory, and the Director of Microbiology unit as well as a study physician for AIDS Vaccine clinical and feasibility research at Project San Francisco.

He has published papers in several international and regional peer-reviewed journals and has made numerous presentations in international conferences. His research interests include evaluation of diagnostic methods (molecular and serological) for infectious diseases and operational research on diagnostic implementation and scale up to assess the impact of the new diagnostic for infectious diseases.

Comments are closed.